Ultra Clean Systems, a US manufacturer of medical grade ultrasonic cleaning systems for surgical instruments based in Tampa, Florida, has secured exclusive North American distribution rights for the patented ProReveal fluorescence protein testing system, which was created by Synoptics Health, based in Cambridge, UK.
By using a highly-sensitive non-toxic spray and fluorescence imaging, the system provides a detection test which checks for the presence of residual protein on surgical instruments after going through a washer disinfector process. In contrast to methods currently used in US hospitals and surgical centres, ProReveal's test delivers accurate and measurable results in real-time 3D which remove any doubt as to whether a 'decontaminated' instrument is safe for reuse.
In addition to increased levels of accuracy and consistency, ProReveal is easy to use, facilitating seamless integration into current reprocessing protocols. Once an instrument is sprayed with a reagent, it is placed into the ProReveal unit, and, using a simple interface, a full-colour 2D image is taken of the instrument clearly showing where and how much protein is present. A 3D representation can also be displayed which shows the concentration of protein.
The devices, sprays and testing procedures were originally developed by David Perrett, Professor of Bioanalytical Science, Nanda K. Nayuni, Post-doctoral Researcher Bioanalysis, William Harvey Research Institute, Barts & the London School of Medicine and Dentistry, Queen Mary University of London, with the aim of overcoming the sterilisation issues with current procedures.
